Immupharma Plc (IMM) Ordinary 1p

- Add to watchlist
- Create an alert
- This stock can be held in a




3.90p
4.50p
7.26p
£14.20 million
3.36p
3.32p
0.85p
n/a
0.11p (3.23%) Previous:
0.11p
13,662,400
n/a
150,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/12/2023 | 31/12/2022 |
---|---|---|
Revenue (£m) | n/a | n/a |
Profit before tax (£m) | (3.42) | (4.46) |
Adjusted EPS (p): | (0.81) | (1.26) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
ImmuPharma can't explain near-400% stock jump
28 January 2025 13:09
-
ImmuPharma progresses P140 clinical programme with FDA
12 April 2023 14:13
-
ImmuPharma upbeat after meeting with US partner Avion
11 November 2022 13:04
-
ImmuPharma proves unique Mechanism of Action-P140
13 March 2025 07:00
-
Holding(s) in Company
21 February 2025 11:36
-
£2.91m fundraising; related party transactions
13 February 2025 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.